Literature DB >> 22427412

Work status and its determinants among patients with systemic sclerosis: a systematic review.

Anne A Schouffoer1, Jan W Schoones, Caroline B Terwee, Theodora P M Vliet Vlieland.   

Abstract

OBJECTIVE: To describe work status and factors associated with work disability (WD) in patients with SSc.
METHODS: A systematic search strategy in various electronic databases from 1990 to 2011 was performed. All clinical studies concerning SSc patients containing quantitative information on work status and/or factors associated with WD were selected. Extracted were study characteristics, data on work status and/or factors associated with WD. The methodological quality was evaluated in three quality aspects (selection bias, information bias and statistical analysis bias). A best evidence synthesis was employed to analyse the association between potential determinants and WD.
RESULTS: Twelve studies, described in 13 papers, including 2758 SSc patients were selected. The methodological quality of one study was high. Employment rates varied between 11 and 82% after an average disease duration ranging from 2.5 to 14 years. There was moderate evidence for an association between more functional disability, more disease-specific symptoms and poorer quality of life on one side and presence of WD on the other. There was moderate evidence for the absence of an association between WD and age, sex and disease subset. Inconsistent evidence was seen for an association between WD and education and disease duration.
CONCLUSION: WD is a major consequence of the disease in patients with SSc and is associated with more functional disability, more disease-specific symptoms and poorer quality of life. This emphasizes the need for research into interventions to prevent or reduce WD in patients with SSc, especially in those with a poorer health status.

Entities:  

Mesh:

Year:  2012        PMID: 22427412     DOI: 10.1093/rheumatology/ker523

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  6 in total

Review 1.  Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.

Authors:  Natalie McCormick; Carlo A Marra; J Antonio Aviña-Zubieta
Journal:  Curr Rheumatol Rep       Date:  2017-10-30       Impact factor: 4.592

2.  Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study.

Authors:  P T Chan; C C Mok; K L Chan; L Y Ho
Journal:  Clin Rheumatol       Date:  2014-02-16       Impact factor: 2.980

3.  LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients.

Authors:  Ivan Castellví; Saioa Eguiluz; Alejandro Escudero-Contreras; Juan José Ríos; Jaime Calvo-Alén; José Luis Callejas-Rubio; Carlos De la Puente; Carmen Pilar Simeón; Francisco Javier Narváez; Gerard Espinosa; Patricia E Carreira; Manuel Rubio-Rivas; Juan José Alegre; Alfredo Guillén-Del-Castillo; Jose Andrés Román-Ivorra; Vicent Fonollosa
Journal:  Rheumatol Int       Date:  2019-09-14       Impact factor: 2.631

4.  Effect of a tailored home-based exercise program in patients with systemic sclerosis: A randomized controlled trial.

Authors:  Mirko Filippetti; Lucia Cazzoletti; Francesco Zamboni; Pietro Ferrari; Cristian Caimmi; Nicola Smania; Stefano Tardivo; Marcello Ferrari
Journal:  Scand J Med Sci Sports       Date:  2020-05-11       Impact factor: 4.221

5.  Work Productivity and Economic Burden of Systemic Sclerosis in a Multiethnic Asian Population.

Authors:  Ling Xiang; Sandra M Y Kua; Andrea H L Low
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-12       Impact factor: 5.178

Review 6.  Does total hip replacement affect sexual quality of life?

Authors:  Rita Th E Harmsen; Tsjitske M Haanstra; Inger N Sierevelt; Elise P Jansma; Peter A Nolte; Melianthe P J Nicolai; Peter D H Wall; Barend J Van Royen
Journal:  BMC Musculoskelet Disord       Date:  2016-05-04       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.